drugset / Trial / NCT01760889
SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to determine whether SPD489 low dose range (40, 80, or 100mg) and high dose range (120, 140, or 160mg) are effective in the treatment of Negative Symptoms.
Timeline
- Start
- 2013-02-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lisdexamfetamine Dimesylate | Small molecule | 80 mg | — |
| Subject | Lisdexamfetamine Dimesylate | Small molecule | 100 mg | — |
| Subject | Lisdexamfetamine Dimesylate | Small molecule | 140 mg | — |
| Subject | Lisdexamfetamine Dimesylate | Small molecule | 160 mg | — |